NRG-BR007
Open to Accrual
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Principal Investigator
Status
Open to Accrual
Date Opened To Accrual
June 7, 2021
Disease Site
Breast [BR] Breast
Phase
III
Developmental Therapeutics
No
Primary Objective
To evaluate whether breast conservation surgery and endocrine therapy results in a
non-inferior rate of ipsilateral-breast tumor recurrence (IBTR) compared to
breast conservation with breast radiation and endocrine therapy.
Target Accrual
1670
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
To learn more about this study, visit the Patient Study Webpage.
-
Share this study.
-
-
-
-
